0000000000437441

AUTHOR

N Kudelin

showing 4 related works from this author

The Influence of the Primary Tumor on the Long-term Results of Pulmonary Metastasectomy for Metastatic Renal Cell Carcinoma

2011

OBJECTIVE To investigate one of the primary tumor (PT) on pulmonary metastasectomy (PM) for metastatic renal cell carcinoma (RCC) and to define prognostic factors. METHODS Retrospective review of patients with pulmonary metastases from RCC from January 1999 through December 2008 was performed. All patients underwent PM with curative intend. TNM-classification, tumor stage and PT grade, disease-free-interval (DFI) from nephrectomy to the diagnosis of metastasis, systemic chemotherapy before surgical intervention, surgical procedures, morbidity, mortality, and survival were investigated. RESULTS One-hundred seven consecutive patients (age 61.5 ± 9.6 years) underwent PM. Morbidity and mortalit…

AdultMalePulmonary and Respiratory MedicineOncologymedicine.medical_specialtyLung NeoplasmsTime Factorsmedicine.medical_treatmentUrologyKaplan-Meier EstimateNephrectomyRisk AssessmentRisk FactorsRenal cell carcinomaInternal medicinemedicineAdjuvant therapyHumansPneumonectomyCarcinoma Renal CellAgedNeoplasm StagingProportional Hazards ModelsRetrospective StudiesAged 80 and overUnivariate analysisProportional hazards modelbusiness.industryMortality rateMetastasectomyMiddle Agedmedicine.diseasePrimary tumorKidney NeoplasmsNeoadjuvant TherapyNephrectomyTreatment OutcomeChemotherapy AdjuvantLymphatic MetastasisMultivariate AnalysisFemaleSurgeryNeoplasm GradingMetastasectomyCardiology and Cardiovascular MedicinebusinessThe Thoracic and Cardiovascular Surgeon
researchProduct

Metastasectomy With Standardized Lymph Node Dissection for Metastatic Renal Cell Carcinoma: An 11-Year Single-Center Experience

2013

Background Pulmonary metastasectomy (PM) for metastatic renal cell carcinoma is an established method of treatment for selected patients. The incidence of intrathoracic lymph node metastases (ITLNM) and outcomes remain controversial. The purpose of this study was to determine the incidence of ITLNM and long-term outcome of PM for metastatic kidney cancer. Methods From January 1999 to December 2009, 116 patients (82 men, age 61.7 ± 9.0 years) with metastases from kidney cancer underwent PM and systematic lymph node dissection with curative intent. Kaplan-Meier analyses, log-rank test, and Cox regression analyses were used to estimate survival and to determine prognosticators of survival. Res…

AdultMalePulmonary and Respiratory Medicinemedicine.medical_specialtyAdolescentThoracic CavityKaplan-Meier EstimateYoung AdultRenal cell carcinomaGermanymedicineHumansCarcinoma Renal CellLymph nodeAgedProportional Hazards ModelsRetrospective StudiesAged 80 and overUnivariate analysisProportional hazards modelbusiness.industryMortality rateMetastasectomyMiddle Agedmedicine.diseaseKidney NeoplasmsIntrathoracic Lymph NodeSurgerySurvival Ratemedicine.anatomical_structureLymphatic MetastasisLymph Node ExcisionFemaleSurgeryMetastasectomyCardiology and Cardiovascular MedicinebusinessKidney cancerForecastingThe Annals of Thoracic Surgery
researchProduct

Risk factors for lymph node metastases and prognosticators of survival in patients undergoing pulmonary metastasectomy for colorectal cancer.

2013

Background Systematic lymph node dissection is not routinely performed in patients undergoing pulmonary metastasectomy (PM) of colorectal cancer. The aim of the study was to identify risk factors for lymph node metastases (LNM) and to determine prognosticators for survival in colorectal cancer patients with pulmonary metastases. Methods We retrospectively reviewed our prospective database of 165 patients with colorectal cancer undergoing PM and systematic lymph node dissection with curative intent from 1999 to 2009. The χ 2 test, regression analyses, Kaplan-Meier analyses, log rank tests, and Cox regression analyses were used to determine prognosticators for LNM and survival. Results The pr…

Pulmonary and Respiratory MedicineOncologyAdultMalemedicine.medical_specialtyLung NeoplasmsColorectal cancermedicine.medical_treatmentRisk FactorsInternal medicinemedicineHumansLymph nodeAgedChemotherapyProportional hazards modelbusiness.industryMetastasectomyMiddle Agedmedicine.diseasePrognosisPrimary tumorLog-rank testDissectionmedicine.anatomical_structureLymphatic MetastasisLymph Node ExcisionSurgeryFemaleMetastasectomyCardiology and Cardiovascular MedicinebusinessColorectal NeoplasmsThe Annals of thoracic surgery
researchProduct

Factors predicting poor survival after lung-sparing radical pleurectomy of IMIG stage III malignant pleural mesothelioma.

2012

OBJECTIVES: The role of radical pleurectomy (RP) in the management of IMIG stage III in malignant pleural mesothelioma (MPM) remains controversial. The aim of the study was to investigate the feasibility and outcome as well as to determine factors predicting poor survival. METHODS: Patients having IMIG stage III MPM were identified within a prospective multimodality treatment study (RP followed by chemoradiation) between 2002 and 2010 at a single institution. Kaplan–Meier analyses, log-rank test and Cox regression analyses were used to estimate survival and to determine predictors of survival. RESULTS: A total of 78 patients (66.3 ± 2.5 years, 65 males) underwent RP followed by chemoradiati…

Pulmonary and Respiratory MedicineMaleMesotheliomamedicine.medical_specialtyLung NeoplasmsKaplan-Meier EstimatemedicineHumansMesotheliomaProgression-free survivalStage (cooking)LungAgedProportional Hazards ModelsUnivariate analysisProportional hazards modelbusiness.industryHazard ratioMesothelioma MalignantGeneral MedicineChemoradiotherapyMiddle Agedmedicine.diseaseSurgeryLog-rank testPleuraSurgeryFemaleCardiology and Cardiovascular MedicinebusinessOrgan Sparing TreatmentsChemoradiotherapyEuropean journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
researchProduct